Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Heron Therapeutics Inc (HRTX) vs Micron Technology, Inc. (MU) Price & Performance

Heron Therapeutics IncTrade
Micron Technology, Inc.Trade

Price performance (Past 24H)

Key statistics

Heron Therapeutics Inc vs Micron Technology, Inc. — how do they compare? Heron Therapeutics Inc trades at $0.32 (market cap $63.41M), while Micron Technology, Inc. trades at $892.69 (market cap $972.41B). The key difference: Micron Technology, Inc. is far larger — about 15335.3× Heron Therapeutics Inc's market cap, and Micron Technology, Inc. pays a 0.06% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.

HRTXMU
Market Cap
$63.41M$972.41B
Sector
HealthTechnology
52-Week High
$1.49$1.21K
52-Week Low
$0.32$115.79
Enterprise Value
$161.31M$952.76B
Dividend Yield
0.06%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Heron Therapeutics Inc

Heron Therapeutics (HRTX) trades at $0.49, down 1.64% today, with a bearish technical signal from moving averages. The company reported Q2 2026 revenue of $37.7M but missed earnings expectations with a $0.03 loss per share. Despite negative net income margins, HRTX maintains strong analyst support with 94.7% buy ratings. Recent news highlights patent litigation developments and quarterly earnings underperformance.

HRTX faces significant fundamental challenges with persistent losses and declining revenue projections, though analyst consensus remains overwhelmingly bullish. Investment opportunity exists if the company can achieve profitability and meet growth targets, but risks include ongoing operational losses, competitive pressures, and execution challenges in the biotechnology sector.

Micron Technology, Inc.

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Heron Therapeutics Inc

Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.

Read more on HRTX

About Micron Technology, Inc.

Micron historically focused on designing and manufacturing DRAM for PCs. The firm then expanded into the NAND flash memory market. It increased its DRAM scale with the purchase of Elpida (completed in mid-2013) and Inotera (completed in December 2016). The firm's DRAM and NAND products tailored to PCs, data centers, smartphones, game consoles, automotives, and other computing devices.

Read more on MU